Cargando…
Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264931/ https://www.ncbi.nlm.nih.gov/pubmed/32544863 http://dx.doi.org/10.1016/j.msard.2020.102244 |
_version_ | 1783541033507749888 |
---|---|
author | Meca-Lallana, Virginia Aguirre, Clara Cardeñoso, Laura Alarcon, Teresa Figuerola-Tejerina, Angels del Río, Beatriz Álvarez, Miguel Ruiz Vivancos, José |
author_facet | Meca-Lallana, Virginia Aguirre, Clara Cardeñoso, Laura Alarcon, Teresa Figuerola-Tejerina, Angels del Río, Beatriz Álvarez, Miguel Ruiz Vivancos, José |
author_sort | Meca-Lallana, Virginia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7264931 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72649312020-06-02 Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic Meca-Lallana, Virginia Aguirre, Clara Cardeñoso, Laura Alarcon, Teresa Figuerola-Tejerina, Angels del Río, Beatriz Álvarez, Miguel Ruiz Vivancos, José Mult Scler Relat Disord Correspondence Elsevier B.V. 2020-09 2020-06-02 /pmc/articles/PMC7264931/ /pubmed/32544863 http://dx.doi.org/10.1016/j.msard.2020.102244 Text en © 2020 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Correspondence Meca-Lallana, Virginia Aguirre, Clara Cardeñoso, Laura Alarcon, Teresa Figuerola-Tejerina, Angels del Río, Beatriz Álvarez, Miguel Ruiz Vivancos, José Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic |
title | Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic |
title_full | Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic |
title_fullStr | Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic |
title_full_unstemmed | Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic |
title_short | Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic |
title_sort | establishment of a safety protocol for the administration of treatments in multiple sclerosis during the sars-cov-2 pandemic |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264931/ https://www.ncbi.nlm.nih.gov/pubmed/32544863 http://dx.doi.org/10.1016/j.msard.2020.102244 |
work_keys_str_mv | AT mecalallanavirginia establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic AT aguirreclara establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic AT cardenosolaura establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic AT alarconteresa establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic AT figuerolatejerinaangels establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic AT delriobeatriz establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic AT alvarezmiguelruiz establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic AT vivancosjose establishmentofasafetyprotocolfortheadministrationoftreatmentsinmultiplesclerosisduringthesarscov2pandemic |